Custom Search


Friday 01 March 2002

Olanzapine augmentation in the treatment of melancholia: the trajectory of improvement in rapid responders.

By: Parker G.

Int Clin Psychopharmacol 2002 Mar;17(2):87-9

It has been suggested that the atypical antipsychotic drugs may induce a rapid improvement in individuals with melancholic depression. This might reflect a specific or non-specific effect on mood and other parameters. To examine this issue, ten consecutive patients, for whom olanzapine augmentation was judged a clinically appropriate strategy, were asked to complete daily ratings of depression severity and component features for 1 week. Of the six rapid responders, there was a 52% group improvement in the first day and 89% improvement at 1 week. Item analyses suggested the most rapid impact was evident for insomnia, compared to a slower and linear improvement in depressed mood. Such findings may assist in an understanding of the mechanisms underlying augmentation with atypical neuroleptic drugs.

Use of this site is subject to the following terms of use